Fidelity Advisor Backtesting

FBTAX -- USA Fund  

USD 24.78  0.28  1.12%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Fidelity Advisor Biotechnology and determine expected loss or profit from investing in Fidelity Advisor over given investment horizon. Additionally see Fidelity Advisor Hype Analysis, Fidelity Advisor Correlation, Portfolio Optimization, Fidelity Advisor Volatility as well as analyze Fidelity Advisor Alpha and Beta and Fidelity Advisor Performance.
Horizon     30 Days    Login   to change
SymbolX
Backtest

Fidelity Advisor 'What if' Analysis

July 21, 2019
0.00
No Change 0.00  0.0 
In 3 months and 1 day
October 19, 2019
0.00
If you would invest  0.00  in Fidelity Advisor on July 21, 2019 and sell it all today you would earn a total of 0.00 from holding Fidelity Advisor Biotechnology or generate 0.0% return on investment in Fidelity Advisor over 90 days. Fidelity Advisor is related to or competes with T Rowe, Vanguard HealthCare, BlackRock HlthSc, BlackRock HlthSc, BlackRock Health, Fidelity Advisor, and Janus Henderson. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, develo...

Fidelity Advisor Upside/Downside Indicators

Information Ratio(0.04141)
Maximum Drawdown6.19
Value At Risk(2.14)
Potential Upside1.97

Fidelity Advisor Market Premium Indicators

Risk Adjusted Performance(0.05)
Jensen Alpha(0.06)
Total Risk Alpha(0.043345)
Treynor Ratio(0.09)

Fidelity Advisor Bio Backtested Returns

Macroaxis considers Fidelity Advisor to be not too volatile. Fidelity Advisor Bio secures Sharpe Ratio (or Efficiency) of -0.0442 which denotes the fund had -0.0442% of return per unit of risk over the last 3 months. Macroaxis philosophy towards predicting risk of any fund is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Fidelity Advisor Biotechnology exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Fidelity Advisor Bio Coefficient Of Variation of (1,731) and Mean Deviation of 0.9854 to check risk estimate we provide. The organization shows Beta (market volatility) of 0.9127 which denotes to the fact that Fidelity Advisor returns are very sensitive to returns on the market. as market goes up or down, Fidelity Advisor is expected to follow. Even though it is essential to pay attention to Fidelity Advisor Bio historical returns, it is always good to be careful when utilizing equity current trending patterns. Macroaxis philosophy towards predicting future performance of any fund is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Fidelity Advisor Biotechnology exposes twenty-one different technical indicators which can help you to evaluate its performance.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.14) 
correlation synergy

Insignificant reverse predictability

Fidelity Advisor Biotechnology has insignificant reverse predictability. Overlapping area represents the amount of predictability between Fidelity Advisor time series from July 21, 2019 to September 4, 2019 and September 4, 2019 to October 19, 2019. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fidelity Advisor Bio price movement. The serial correlation of -0.14 indicates that less than 14.0% of current Fidelity Advisor price fluctuation can be explain by its past prices. Given that Fidelity Advisor Biotechnology has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Fidelity Advisor for similar time interval.
Correlation Coefficient-0.14
Spearman Rank Test0.23
Residual Average0.0
Price Variance0.31

Fidelity Advisor Bio lagged returns against current returns

 Current and Lagged Values 
      Timeline 

Fidelity Advisor regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

Fidelity Advisor Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - FBTAX

Fidelity Advisor Bio Investor Sentiment

Most of Macroaxis users are currently bullish on Fidelity Advisor Biotechnology. What is your opinion about investing in Fidelity Advisor Biotechnology? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally see Fidelity Advisor Hype Analysis, Fidelity Advisor Correlation, Portfolio Optimization, Fidelity Advisor Volatility as well as analyze Fidelity Advisor Alpha and Beta and Fidelity Advisor Performance. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.
Search macroaxis.com